Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00852254 · ClinicalTrials.gov registry record
Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children
A clinical trial, sponsored by Transonic Systems.
- Completed
- Registry status
- 9
- Enrollment target
NCT00852254: Completed study, sponsored by Transonic Systems.
NCT00852254 is a clinical trial that has completed, run by Transonic Systems. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00852254 has completed, sponsored by Transonic Systems.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
A novel method to measure cardiac index based on ultrasound indicator dilution technology (UIDT) has been developed by Transonic Systems Inc. (Ithaca, NY, USA). The method overcomes many of the limitations that have plagued the existing techniques used to measure cardiac index in critically ill children. In the proposed investigation, the investigators hope to validate a novel application of an existing technology in critically ill infants and children. The primary aim of this study is to determine the accuracy of cardiac index measured by UIDT when compared to the gold-standard Fick technique. The primary hypothesis is that the average of three consecutive measurements of cardiac index by UIDT will be accurate when compared to the Fick technique. Secondary aims will be to determine the precision of the measurement, the feasibility of the technique with regards to time required and any complications encountered. An exploratory secondary aim of this study is to determine whether central blood volume (CBV) derived from indicator transit time (ITT) correlates with central venous pressure (CVP) and echocardiography derived measures of preload.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-05 |
What the finished NCT00852254 record still lists
NCT00852254 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00852254 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00852254 about?
NCT00852254 is a clinical study titled "Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children". A novel method to measure cardiac index based on ultrasound indicator dilution technology (UIDT) has been developed by Transonic Systems Inc. (Ithaca, NY, USA). The method overcomes many of the limitations that have plagued the existing techniques used to measure cardiac index in critically ill chil...
What is the current status of trial NCT00852254?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2008-06. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT00852254?
This trial is sponsored by Transonic Systems, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia